Microsoft has ended support for its pre-IE11 browsers as of January 2016 and will be discontinuing IE11 support in August 2021.

If you are seeing this message, you are viewing the site on one of these unsupported browsers. We only support the recent versions of major browsers such as Chrome, Firefox, Safari, and Edge.

Thank you.

(click to close and continue using this browser)

contact privacy policy profile Search log in


The SUO-CTC is lead and managed by an independent Board of Directors which includes a President, Past President, and Secretary-Treasurer along with the President, President-Elect, Secretary and Treasurer of the SUO.

Additionally the leadership includes a Clinical Trials Committee; members are experts in urologic cancers with organ site committees focused on bladder, prostate, and renal cancers.

The role of the Committee is to coordinate clinical trial activity and to identify novel therapeutic strategies with potential impact on genitourinary malignancies.

With executive offices in Schaumburg Illinois, the SUO-CTC regularly receives queries from industry and other interested parties to assist with clinical projects across the research continuum. The SUO-CTC executive management, in working with the Board of Directors and Clinical Trials Committee, is equipped to quickly facilitate a number of services including organ site specific project review and feedback, site feasibility, site recommendation, ongoing centralized communications, and member participation on advisory boards.